XML 148 R94.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings per Share (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Numerator:                      
Net income attributable to Biogen Idec Inc $ 946.8 $ 1,444.4 $ 866.6 $ 1,172.9 $ (297.4) $ 1,226.1 $ 862.8 $ 747.6 $ 4,430.7 $ 2,539.1 $ 3,702.8
Denominator:                      
Weighted average number of common shares outstanding 199.8 201.4 207.1 211.4 211.5 211.4 211.9 215.6 204.9 212.6 218.4
Effect of dilutive securities:                      
Dilutive potential common shares                 0.4 0.4 0.4
Shares used in calculating diluted earnings per share 200.3 201.9 207.3 211.7 212.0 211.8 212.2 215.9 205.3 213.0 218.8
Earnings per share (Textual)                      
Repurchase of common stock                 14.8 3.7 0.7
Stock options and employee stock purchase plan                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan                 0.0 0.1 0.1
Time-vested restricted stock units                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan                 0.3 0.2 0.2
Market stock units                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan                 0.1 0.1 0.1
Performance stock units settled in stock                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan                 0.0 0.0 0.0